Trace elements in human physiology and pathology: zinc and metallothioneins.
暂无分享,去创建一个
[1] E. Tibaduiza,et al. Zinc transport across an endothelium includes vesicular cotransport with albumin , 1996, Journal of cellular physiology.
[2] Milos Chuapil. Effect of zinc on cells and biomembranes. , 1976 .
[3] J. Beattie,et al. Metallothionein and the trace minerals. , 1990, Annual review of nutrition.
[4] R. Ravid,et al. Increased amount of zinc in the hippocampus and amygdala of Alzheimer's diseased brains A proton-induced X-ray emission spectroscopic analysis of cryostat sections from autopsy material , 1997, Journal of Neuroscience Methods.
[5] L. Mucke,et al. Amyloidogenic role of cytokine TGF-β1 in transgenic mice and in Alzheimer's disease , 1997, Nature.
[6] P. G. Reeves. Adaptation responses in rats to long-term feeding of high-zinc diets: emphasis on intestinal metallothionein , 1995 .
[7] J. Hesketh. Zinc binding to tubulin. , 1983, The International journal of biochemistry.
[8] Rudolph E Tanzi,et al. Presenilins and Alzheimer's disease , 1997, Current Opinion in Neurobiology.
[9] B. Lönnerdal. Intestinal Absorption of Zinc , 1989 .
[10] B. Vallee,et al. The biochemical basis of zinc physiology. , 1993, Physiological reviews.
[11] R. Palmiter,et al. ZnT-3, a putative transporter of zinc into synaptic vesicles. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[12] S. Choudhuri,et al. Species variation in hepatic metallothionein. , 1994, Toxicology letters.
[13] Diponkar Banerjee,et al. IMMUNOHISTOCHEMICAL LOCALIZATION OF METALLOTHIONEIN IN CELL NUCLEUS AND CYTOPLASM OF FETAL HUMAN LIVER AND KIDNEY AND ITS CHANGES DURING DEVELOPMENT , 1987, Pathology.
[14] Y. Masuda,et al. Zinc ions prevent processing of caspase-3 during apoptosis induced by geranylgeraniol in HL-60 cells. , 1998, Journal of biochemistry.
[15] C. F. Mills. Zinc in Human Biology , 1989, ILSI Human Nutrition Reviews.
[16] Jie Liu,et al. Metallothionein: an intracellular protein to protect against cadmium toxicity. , 1999, Annual review of pharmacology and toxicology.
[17] W. Maret,et al. The ATP-metallothionein complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[18] Sunderman Fw. The influence of zinc on apoptosis , 1995 .
[19] J. Halsted,et al. Zinc deficiency in man. The Shiraz experiment. , 1972, The American journal of medicine.
[20] W. Bettger,et al. The physiological role of zinc as an antioxidant. , 1990, Free radical biology & medicine.
[21] G. Reynolds,et al. Hippocampal tin, aluminum and zinc in Alzheimer's disease , 2004, Biometals.
[22] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[23] J. Youn,et al. Interactions of metallothionein with murine lymphocytes: plasma membrane binding and proliferation. , 1996, Toxicology.
[24] G. Glenner,et al. Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein , 1984 .
[25] W. Maret,et al. Control of zinc transfer between thionein, metallothionein, and zinc proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[26] R. Cousins,et al. Cysteine-rich intestinal protein and intestinal metallothionein: an inverse relationship as a conceptual model for zinc absorption in rats. , 1992, The Journal of nutrition.
[27] W. D. Ehmann,et al. Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain. , 1998, Neurotoxicology.
[28] R. Cousins,et al. Cysteine-rich intestinal protein binds zinc during transmucosal zinc transport. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[29] P. Wright,et al. Electron transfer from cytochrome b5 to iron and copper complexes. , 1987, Biochemistry.
[30] B. Winegar,et al. Voltage‐dependent block by zinc of single calcium channels in mouse myotubes. , 1990, The Journal of physiology.
[31] Y. Iiboshi,et al. Induction of Nitric Oxide Synthase in Rat Intestine by Interleukin-1α May Explain Diarrhea Associated with Zinc Deficiency , 1997 .
[32] D. Evans,et al. The dihydroorotase domain of the multifunctional protein CAD. Subunit structure, zinc content, and kinetics. , 1986, The Journal of biological chemistry.
[33] R. Lockshin,et al. Programmed cell death. , 1974, Life sciences.
[34] Y. Lazebnik,et al. Caspases: enemies within. , 1998, Science.
[35] A. Van der Laarse,et al. Isoproterenol-induced cytotoxicity in neonatal rat heart cell cultures is mediated by free radical formation. , 1989, Journal of molecular and cellular cardiology.
[36] E. Stadtman,et al. Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.
[37] W. Bettger,et al. Zinc deficiency alters the protein composition of the membrane skeleton but not the extractability or oligomeric form of spectrin in rat erythrocyte membranes. , 1992, The Journal of nutrition.
[38] R. Palmiter,et al. Metallothionein III is expressed in neurons that sequester zinc in synaptic vesicles , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[39] D. Butterfield,et al. Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation , 1995, Journal of neurochemistry.
[40] A. Prasad,et al. Biochemical studies on dwarfism, hypogonadism, and anemia. , 1963, Archives of internal medicine.
[41] S. Samson,et al. Molecular analyses of metallothionein gene regulation. , 1998, Progress in nucleic acid research and molecular biology.
[42] C. Masters,et al. A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. , 1993, The Journal of biological chemistry.
[43] D. Choi,et al. Zinc toxicity on cultured cortical neurons: Involvement of N-methyl-d-aspartate receptors , 1994, Neuroscience.
[44] R. Cousins,et al. Metal elements and gene expression. , 1994, Annual review of nutrition.
[45] Robert M. Russell,et al. Present Knowledge in Nutrition , 2001 .
[46] D. Oberleas. Mechanism of zinc homeostasis. , 1996, Journal of inorganic biochemistry.
[47] R. Cousins,et al. Tissue‐specific regulation of zinc metabolism and metallothionein genes by interleukin 1 , 1988, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] K. P. Singh,et al. Effect of zinc on immune functions and host resistance against infection and tumor challenge. , 1992, Immunopharmacology and immunotoxicology.
[49] N. Fabris. Immune System and Aging: Neuroimmunological Implications , 1992 .
[50] R. Cousins. Systemic Transport of Zinc , 1989 .
[51] L. Rink,et al. The significance of zinc for leukocyte biology , 1998, Journal of leukocyte biology.
[52] P. Scuderi,et al. Differential effects of copper and zinc on human peripheral blood monocyte cytokine secretion. , 1990, Cellular immunology.
[53] D. Hamer,et al. Cell specificity and an effect of ras on human metallothionein gene expression. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[54] D. Lawrence,et al. Extracellular metallothionein effects on lymphocyte activities. , 1990, Molecular immunology.
[55] W. Telford,et al. Preferential induction of apoptosis in mouse CD4+CD8+αβTCRIoCD3εIo thymocytes by zinc , 1995 .
[56] B. L. O’dell,et al. Effect of Zinc Deficiency on Enzyme Activities in Rat and Pig Erythrocyte Membranes 1 , 1990, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[57] C. Masters,et al. Amyloid plaque core protein in Alzheimer disease and Down syndrome. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[58] C. E. Hildebrand,et al. Human metallothionein genes: structure of the functional locus at 16q13. , 1990, Genomics.
[59] F. Catalanotto,et al. Zinc profiles in rheumatoid arthritis. , 1990, Clinical and experimental rheumatology.
[60] C. Tohyama,et al. POSSIBLE ROLE OF METALLOTHIONEIN IN THE CELLULAR DEFENSE MECHANISM AGAINST UVB IRRADIATION IN NEONATAL HUMAN SKIN FIBROBLASTS , 1994 .
[61] R. Foster,et al. Cell-type specific and differential regulation of the human metallothionein genes. Correlation with DNA methylation and chromatin structure. , 1990, The Journal of biological chemistry.
[62] M. Ruz,et al. Erythrocytes, erythrocyte membranes, neutrophils and platelets as biopsy materials for the assessment of zinc status in humans , 1992, British Journal of Nutrition.
[63] D. Bagchi,et al. Comparative in vitro oxygen radical scavenging ability of zinc methionine and selected zinc salts and antioxidants. , 1997, General pharmacology.
[64] M. Panemangalore,et al. Changes in the intracellular accumulation and distribution of metallothionein in rat liver and kidney during postnatal development. , 1983, Developmental biology.
[65] A. Prasad. Zinc in human health: An update , 1998 .
[66] J. Haeggström,et al. Zinc and other divalent cations inhibit purified leukotriene A4 hydrolase and leukotriene B4 biosynthesis in human polymorphonuclear leukocytes. , 1994, Archives of biochemistry and biophysics.
[67] P. Casey,et al. Identification of a Cysteine Residue Essential for Activity of Protein Farnesyltransferase , 1996, The Journal of Biological Chemistry.
[68] G. Andrews,et al. Regulation of metallothionein gene expression by oxidative stress and metal ions. , 2000, Biochemical pharmacology.
[69] J. Lazo,et al. Metallothioneins and cell death by anticancer drugs. , 1995, Annual review of pharmacology and toxicology.
[70] M. Failla,et al. Degradation of rat liver metallothioneins in vitro. , 1978, Biochimica et biophysica acta.
[71] G. Lees,et al. Nitric oxide generators produce accumulation of chelatable zinc in hippocampal neuronal perikarya , 1998, Brain Research.
[72] G. Multhaup. Amyloid precursor protein, copper and Alzheimer's disease. , 1997, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[73] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[74] B. L. O’dell,et al. Physiological roles of zinc in the plasma membrane of mammalian cells , 1993 .
[75] J. Lazo,et al. Metallothionein null cells have increased sensitivity to anticancer drugs. , 1995, Cancer research.
[76] H. Sandstead. Zinc deficiency. A public health problem? , 1991, American journal of diseases of children.
[77] C. Masters,et al. The Amyloid Precursor Protein of Alzheimer's Disease in the Reduction of Copper(II) to Copper(I) , 1996, Science.
[78] M. Smith,et al. Oxidative stress in Alzheimer's disease. , 2000, Biochimica et biophysica acta.
[79] C. Masters,et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. , 1994, Science.
[80] J. Hardy,et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene , 1991, Nature.
[81] Y. Lazebnik,et al. Cleavage of lamin A by Mch2 alpha but not CPP32: multiple interleukin 1 beta-converting enzyme-related proteases with distinct substrate recognition properties are active in apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[82] R. Cousins. Absorption, transport, and hepatic metabolism of copper and zinc: special reference to metallothionein and ceruloplasmin. , 1985, Physiological reviews.
[83] P. Zalewski,et al. Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. , 2000, The Journal of nutrition.
[84] R. Colvin,et al. Evidence for a zinc/proton antiporter in rat brain , 2000, Neurochemistry International.
[85] J. Erdman,et al. Bioavailability of trace mineral elements. , 1983, Annual review of nutrition.
[86] J. Koropatnick,et al. Metallothionein protects DNA from copper-induced but not iron-induced cleavage in vitro. , 1995, Chemico-biological interactions.
[87] M. Fukahori,et al. Effects of dietary zinc status on seizure susceptibility and hippocampal zinc content in theEl (epilepsy) mouse , 1990, Brain Research.
[88] R. Palmiter. The elusive function of metallothioneins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[89] L. Raymond,et al. Differential sensitivity of recombinant N-methyl-D-aspartate receptor subtypes to zinc inhibition. , 1997, Molecular pharmacology.
[90] G. Kishore,et al. Identification of the reactive cysteines of Escherichia coli 5-enolpyruvylshikimate-3-phosphate synthase and their nonessentiality for enzymatic catalysis. , 1988, The Journal of biological chemistry.
[91] R. Tanzi,et al. The amyloid beta-protein precursor and its mammalian homologues. Evidence for a zinc-modulated heparin-binding superfamily. , 1994, The Journal of biological chemistry.
[92] P. Iversen,et al. Expression and regulation of brain metallothionein , 1995, Neurochemistry International.
[93] J. Connor,et al. Transferrin and Iron in Normal, Alzheimer's Disease, and Parkinson's Disease Brain Regions , 1995, Journal of neurochemistry.
[94] J. Constantinidis. Maladie d'Alzheimer et la théorie du zinc , 1990 .
[95] M. X. Wu,et al. A cysteine in the C-terminal region of alanyl-tRNA synthetase is important for aminoacylation activity. , 1994, Biochemistry.
[96] Y. Tse‐Dinh,et al. Escherichia coli DNA topoisomerase I is a zinc metalloprotein with three repetitive zinc-binding domains. , 1988, The Journal of biological chemistry.
[97] I. Bremner. Nutritional and physiologic significance of metallothionein. , 1991, Methods in enzymology.
[98] P. Ascher,et al. High-Affinity Zinc Inhibition of NMDA NR1–NR2A Receptors , 1997, The Journal of Neuroscience.
[99] G. Kerchner,et al. Measurement of Intracellular Free Zinc in Living Cortical Neurons: Routes of Entry , 1997, The Journal of Neuroscience.
[100] W. Maret. Metallothionein/disulfide interactions, oxidative stress, and the mobilization of cellular zinc , 1995, Neurochemistry International.
[101] E. Nielsen,et al. Delineation of an endogenous zinc‐binding site in the human dopamine transporter , 1998, The EMBO journal.
[102] J. King,et al. Zinc absorption in women during pregnancy and lactation: a longitudinal study. , 1997, The American journal of clinical nutrition.
[103] S. Powell. The antioxidant properties of zinc. , 2000, The Journal of nutrition.
[104] K. D. Collins,et al. Dihydroorotase from Escherichia coli. Sulfhydryl group-metal ion interactions. , 1986, The Journal of biological chemistry.
[105] B. Sarkar,et al. In Vivo and in Vitro Iron-replaced Zinc Finger Generates Free Radicals and Causes DNA Damage (*) , 1996, The Journal of Biological Chemistry.
[106] Y. Yamada,et al. Probable reaction mechanisms of flavokinase and FAD synthetase from rat liver. , 1990, Archives of biochemistry and biophysics.
[107] R. Palmiter,et al. Cloning and functional characterization of a mammalian zinc transporter that confers resistance to zinc. , 1995, The EMBO journal.
[108] T. Sugiura,et al. Metallothionein in platelets. , 1994, International archives of allergy and immunology.
[109] D. Butterfield,et al. Alternations in lipid membrane fluidity and the physical state of cell-surface sialic acid in zinc-deficient rat erythrocyte ghosts. , 1987, Biochimica et biophysica acta.
[110] K. Lawson,et al. Randomized, double-masked, placebo-controlled clinical study of the effectiveness of zinc acetate lozenges on common cold symptoms in allergy-tested subjects , 1998, Current Therapeutic Research.
[111] C. Fierke,et al. Functional characterization of human carbonic anhydrase II variants with altered zinc binding sites. , 1994, Biochemistry.
[112] R. Palmiter,et al. MT-III, a brain-specific member of the metallothionein gene family. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[113] R. Cousins,et al. Regulation of the zinc transporter ZnT-1 by dietary zinc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[114] J. C. Godfrey,et al. How does zinc modify the common cold? Clinical observations and implications regarding mechanisms of action. , 1996, Medical hypotheses.
[115] Aaron Klug,et al. ‘Zinc fingers’: a novel protein motif for nucleic acid recognition , 1987 .
[116] J. Buring,et al. Micronutrients and HIV‐1 disease progression , 1995, AIDS.
[117] B. Halliwell,et al. Role of free radicals and catalytic metal ions in human disease: an overview. , 1990, Methods in enzymology.
[118] M. Chevion,et al. Zinc(II) protects against metal-mediated free radical induced damage: studies on single and double-strand DNA breakage. , 1991, Free radical research communications.
[119] J. Berg,et al. The Galvanization of Biology: A Growing Appreciation for the Roles of Zinc , 1996, Science.
[120] N. Abramova,et al. Study of antioxidant properties of metal aspartates. , 1995, The Analyst.
[121] W. H. Betts,et al. Correlation of apoptosis with change in intracellular labile Zn(II) using zinquin [(2-methyl-8-p-toluenesulphonamido-6-quinolyloxy)acetic acid], a new specific fluorescent probe for Zn(II). , 1993, The Biochemical journal.
[122] C. Cho,et al. Zinc deficiency: Its role in gastric secretion and stress-induced gastric ulceration in rats , 1987, Pharmacology Biochemistry and Behavior.
[123] E. Shinar,et al. Oxidative damage to human red cells induced by copper and iron complexes in the presence of ascorbate. , 1989, Biochimica et biophysica acta.
[124] R. Dean,et al. Restriction of the participation of copper in radical-generating systems by zinc. , 1991, Free radical research communications.
[125] C. Masters,et al. Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) , 1994, FEBS letters.
[126] P. Dumont,et al. Potentiation of the antitumour activity of 2-formylpyridine thiosemicarbazone by metal chelation : 2-formylpyridine thiosemicarbazone zinc sulphate (NSC 294721). , 1979, European journal of cancer.
[127] P. E. Johnson,et al. Homeostatic control of zinc metabolism in men: zinc excretion and balance in men fed diets low in zinc. , 1993, The American journal of clinical nutrition.
[128] Y. Hannun,et al. Zinc Is a Potent Inhibitor of the Apoptotic Protease, Caspase-3 , 1997, The Journal of Biological Chemistry.
[129] P. Fraker,et al. Possible roles for glucocorticoids and apoptosis in the suppression of lymphopoiesis during zinc deficiency: a review. , 1995, Journal of the American College of Nutrition.
[130] M. Fisman,et al. Metals and the Liver in Alzheimer's Disease An Investigation of Hepatic Zinc, Copper, Cadmium, and Metallothionein , 1990, Journal of the American Geriatrics Society.
[131] D. Wynford‐Thomas,et al. IN VIVO PHOTOINDUCTION OF METALLOTHIONEIN IN HUMAN SKIN BY ULTRAVIOLET IRRADIATION , 1996, The Journal of pathology.
[132] Y. Fukuda,et al. Cytokines and liver disease. , 1991, Japanese journal of medicine.
[133] J. Dórea,et al. Zinc reverses the increased sensitivity of lymphocytes from aged subjects to the antiproliferative effect of prostaglandin E2. , 1992, Clinical immunology and immunopathology.
[134] K. Titani,et al. The growth inhibitory factor that is deficient in the Alzheimer's disease brain is a 68 amino acid metallothionein-like protein , 1991, Neuron.
[135] A. Wyllie,et al. Apoptosis: an overview. , 1997, British medical bulletin.
[136] K. Higashi,et al. Zinc suppresses apoptosis of U937 cells induced by hydrogen peroxide through an increase of the Bcl-2/Bax ratio. , 1998, Biochemical and biophysical research communications.
[137] K. Dakshinamurti,et al. Neurobiology of Pyridoxine a , 1990, Advances in nutritional research.
[138] A. Yang. Abnormal sequestation of lysosomal hydrases in Aβ mediated neurotoxicity. , 1997 .
[139] T. Houbara,et al. Effects of zinc on production of active oxygen species by rat neutrophils. , 1995, Pharmacology & toxicology.
[140] W R Markesbery,et al. Oxidative stress hypothesis in Alzheimer's disease. , 1997, Free radical biology & medicine.
[141] W. Maret,et al. Thiolate ligands in metallothionein confer redox activity on zinc clusters. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[142] G. Lees,et al. Zinc and Alzheimer's disease: is there a direct link? , 1997, Brain Research Reviews.
[143] J. King,et al. Effect of acute zinc depletion on zinc homeostasis and plasma zinc kinetics in men. , 2001, The American journal of clinical nutrition.
[144] J. Fisher,et al. The Role of an α Subtype M2-M3 His in Regulating Inhibition of GABAA Receptor Current by Zinc and Other Divalent Cations , 1998, The Journal of Neuroscience.
[145] R. Tanzi,et al. Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.
[146] I. Paulsen,et al. A Novel Family of Ubiquitous Heavy Metal Ion Transport Proteins , 1997, The Journal of Membrane Biology.
[147] K. Tsujikawa,et al. Induction and subcellular localization of metallothionein in regenerating rat liver. , 1994, European journal of cell biology.
[148] G. Glenner,et al. Differences Between Vascular and Plaque Core Amyloid in Alzheimer's Disease , 1988, Journal of neurochemistry.
[149] Y. J. Kang. The antioxidant function of metallothionein in the heart. , 1999, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[150] D. Harrison,et al. Apoptosis: an overview of the process and its relevance in disease. , 1997, Advances in pharmacology.
[151] P. Hunziker,et al. Isolation and characterization of six human hepatic isometallothioneins. , 1985, The Biochemical journal.
[152] P. Moser-Veillon. Zinc: consumption patterns and dietary recommendations. , 1990, Journal of the American Dietetic Association.
[153] J. King,et al. Zinc homeostasis in humans. , 2000, The Journal of nutrition.
[154] P. Fraker,et al. The dynamic link between the integrity of the immune system and zinc status. , 2000, The Journal of nutrition.
[155] M Chevion,et al. A site-specific mechanism for free radical induced biological damage: the essential role of redox-active transition metals. , 1988, Free radical biology & medicine.
[156] M. Jackson,et al. Physiology of Zinc: General Aspects , 1989 .
[157] Stephan Nussberger,et al. Cloning and characterization of a mammalian proton-coupled metal-ion transporter , 1997, Nature.
[158] J. Catravas,et al. Zn2+ inhibits nitric oxide formation in response to lipopolysaccharides: implication in its anti-inflammatory activity. , 1998, European journal of pharmacology.
[159] C. Cho,et al. Effects of zinc sulphate on ethanol- and indomethacin-induced ulceration and changes in prostaglandin E2 and histamine levels in the rat gastric glandular mucosa. , 1985, Digestion.
[160] W. D. Ehmann,et al. Copper, iron, and zinc imbalances in severely degenerated brain regions in Alzheimer's disease: possible relation to oxidative stress , 1996, Journal of the Neurological Sciences.
[161] K. Kröncke,et al. Measurement of nitric oxide-mediated effects on zinc homeostasis and zinc finger transcription factors. , 1999, Methods in enzymology.
[162] T. Smart,et al. Modulation of GABA‐mediated synaptic transmission by endogenous zinc in the immature rat hippocampus in vitro. , 1994, The Journal of physiology.
[163] R. Palmiter,et al. ZnT‐2, a mammalian protein that confers resistance to zinc by facilitating vesicular sequestration. , 1996, The EMBO journal.
[164] D. Selkoe,et al. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.
[165] S. Traynelis,et al. Control of Voltage-independent Zinc Inhibition of Nmda Receptors by the Nr1 Subunit , 2022 .
[166] J. C. Smith,et al. The role of zinc in bone metabolism. , 1974, Clinical orthopaedics and related research.
[167] R. Palmiter,et al. Induction of a new metallothionein isoform (MT-IV) occurs during differentiation of stratified squamous epithelia. , 1994, Biochemistry.
[168] R. Colvin. Characterization of a plasma membrane zinc transporter in rat brain , 1998, Neuroscience Letters.
[169] S. M. Hadi,et al. DNA breakage by tannic acid and Cu(II): sequence specificity of the reaction and involvement of active oxygen species. , 1994, Mutation research.
[170] P. Hunziker,et al. Isolation, primary structures and metal binding properties of neuronal growth inhibitory factor (GIF) from bovine and equine brain , 1994, FEBS letters.
[171] M. Gershwin,et al. Zinc deficiency and immune function. , 1990, Annual review of nutrition.
[172] M. Gore,et al. Investigation of the effect of metal ions on the reactivity of thiol groups in human 5-aminolaevulinate dehydratase. , 1985, The Biochemical journal.
[173] S. Powell. Salicylate trapping of .OH as a tool for studying post-ischemic oxidative injury in the isolated rat heart. , 1994, Free radical research.
[174] S. Srinivasula,et al. The Ced-3/Interleukin 1β Converting Enzyme-like Homolog Mch6 and the Lamin-cleaving Enzyme Mch2α Are Substrates for the Apoptotic Mediator CPP32* , 1996, The Journal of Biological Chemistry.
[175] N. Andrews,et al. Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[176] R. Palmiter,et al. Disruption of the Metallothionein-III Gene in Mice: Analysis of Brain Zinc, Behavior, and Neuron Vulnerability to Metals, Aging, and Seizures , 1997, The Journal of Neuroscience.
[177] C. Mitchell,et al. Diethyldithiocarbamate and dithizone augment the toxicity of kainic acid , 1990, Brain Research.
[178] R. Henkin,et al. Serum and tissue zinc concentrations in patients with endoscopic esophagitis , 1992, Digestive Diseases and Sciences.
[179] L. Morat,et al. Zinc uptake by proximal cells isolated from rabbit kidney: Effects of cysteine and histidine , 1991, Pflügers Archiv.
[180] R. Vandenberg,et al. Molecular basis for differential inhibition of glutamate transporter subtypes by zinc ions. , 1998, Molecular pharmacology.
[181] W. Maret,et al. The glutathione redox couple modulates zinc transfer from metallothionein to zinc-depleted sorbitol dehydrogenase. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[182] C. Jeandel,et al. Lipid peroxidation and free radical scavengers in Alzheimer's disease. , 1989, Gerontology.